As shown in Fig. 4B–D evidences of C1q binding as well as C3, C9 deposition was clearly documented in tumor sections from mice treated with AT101, whereas it was not visible in samples obtained from unspecific IgM-treated mice. This evidence concerns the gene CD40LG and neoplasm.